DK3688468T3 - Inflammatoriske biomarkører til forudsigelse af modtageligheden for fgf-18 forbindelse - Google Patents

Inflammatoriske biomarkører til forudsigelse af modtageligheden for fgf-18 forbindelse Download PDF

Info

Publication number
DK3688468T3
DK3688468T3 DK18782012.1T DK18782012T DK3688468T3 DK 3688468 T3 DK3688468 T3 DK 3688468T3 DK 18782012 T DK18782012 T DK 18782012T DK 3688468 T3 DK3688468 T3 DK 3688468T3
Authority
DK
Denmark
Prior art keywords
receivability
fgf
prediction
connection
inflammatory biomarkers
Prior art date
Application number
DK18782012.1T
Other languages
English (en)
Inventor
Christoph H Ladel
Hans Guehring
Anne-Christine Bay-Jensen
Morten Karsdal
Per Qvist
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK3688468T3 publication Critical patent/DK3688468T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1825Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK18782012.1T 2017-09-29 2018-09-28 Inflammatoriske biomarkører til forudsigelse af modtageligheden for fgf-18 forbindelse DK3688468T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17194169 2017-09-29
EP18169317 2018-04-25
PCT/EP2018/076391 WO2019063756A1 (en) 2017-09-29 2018-09-28 INFLAMMATORY BIOMARKERS FOR PREDICTING REACTIVITY TO FGF-18 COMPOUND

Publications (1)

Publication Number Publication Date
DK3688468T3 true DK3688468T3 (da) 2022-06-20

Family

ID=63722379

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18782012.1T DK3688468T3 (da) 2017-09-29 2018-09-28 Inflammatoriske biomarkører til forudsigelse af modtageligheden for fgf-18 forbindelse

Country Status (16)

Country Link
US (2) US11467169B2 (da)
EP (1) EP3688468B1 (da)
JP (1) JP7418324B2 (da)
CN (1) CN111164429B (da)
AU (1) AU2018343980A1 (da)
CA (1) CA3075713A1 (da)
DK (1) DK3688468T3 (da)
ES (1) ES2918249T3 (da)
HR (1) HRP20220737T1 (da)
HU (1) HUE058848T2 (da)
IL (1) IL273574B1 (da)
LT (1) LT3688468T (da)
PL (1) PL3688468T3 (da)
RS (1) RS63292B1 (da)
SI (1) SI3688468T1 (da)
WO (1) WO2019063756A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019063758A1 (en) 2017-09-29 2019-04-04 Merck Patent Gmbh METABOLIC BIOMARKERS FOR PREDICTING RESPONSE TO FGF-18 COMPOUND

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100611063B1 (ko) 1996-10-16 2006-08-09 지모제넥틱스, 인코포레이티드 섬유아세포 성장인자 상동체
AU2003279835B2 (en) 2002-10-07 2009-09-10 Zymogenetics, Inc. Methods of administering FGF18
ES2371219T3 (es) 2004-12-10 2011-12-28 Zymogenetics, Inc. Producción de fgf18 en huéspedes procariotas.
JP5815206B2 (ja) 2006-08-25 2015-11-17 アレス トレーディング ソシエテ アノニム Fgf−18を用いた軟骨障害の治療
US10221456B2 (en) 2012-08-06 2019-03-05 Merck Patent Gmbh Genetic markers for predicting responsiveness to FPG-18 compound
WO2015084883A2 (en) * 2013-12-02 2015-06-11 Abbvie, Inc. Compositions and methods for treating osteoarthritis
PT3107559T (pt) * 2014-02-20 2018-10-31 Merck Patent Gmbh Regime posológico de composto de fgf-18
WO2019063758A1 (en) 2017-09-29 2019-04-04 Merck Patent Gmbh METABOLIC BIOMARKERS FOR PREDICTING RESPONSE TO FGF-18 COMPOUND

Also Published As

Publication number Publication date
AU2018343980A1 (en) 2020-04-02
HRP20220737T1 (hr) 2022-09-02
EP3688468B1 (en) 2022-03-16
JP2020535423A (ja) 2020-12-03
RS63292B1 (sr) 2022-06-30
PL3688468T3 (pl) 2022-07-18
EP3688468A1 (en) 2020-08-05
LT3688468T (lt) 2022-06-27
WO2019063756A1 (en) 2019-04-04
SI3688468T1 (sl) 2022-08-31
CN111164429A (zh) 2020-05-15
CN111164429B (zh) 2024-08-09
US20230258659A1 (en) 2023-08-17
ES2918249T3 (es) 2022-07-14
HUE058848T2 (hu) 2022-09-28
IL273574B1 (en) 2024-09-01
US20210231680A1 (en) 2021-07-29
IL273574A (en) 2020-05-31
CA3075713A1 (en) 2019-04-04
US11467169B2 (en) 2022-10-11
JP7418324B2 (ja) 2024-01-19

Similar Documents

Publication Publication Date Title
DK3241026T3 (da) Fremgangsmåde til absolut kvantificering af naturligt forarbejdede hla-begrænsede cancerpeptider
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3244891T3 (da) Forbindelser til forbedring af mrna-splejsning
DK3344805T3 (da) Fremgangsmåde til udvælgelse af aptamerer til ubundne mål
DK3262190T3 (da) Biomarkørpanel til påvisning af cancer
DK3287523T3 (da) Fremgangsmåde til sekretorisk fremstilling af protein
DK3368683T3 (da) Fremgangsmåde til kvantifikationen af pd-l1
DK3481964T3 (da) Biomarkører for inflammatorisk tarmsygdom
DK3304093T3 (da) Validering af biomarkørmåling
DK3455625T3 (da) Fremgangsmåder til forudsigelse af anvendeligheden af neo-antigener til immunterapi
DK3255210T3 (da) Fremgangsmåde til installation af en offshore-struktur
MA43957A (fr) Biomarqueurs de copanlisib
DK3487443T3 (da) Fremgangsmåde til opmåling af en implantat-implantat-situation
DK3612845T3 (da) Fremgangsmåde til kontaktløs bestemmelse af flowparametre
DK3889374T3 (da) Fremgangsmåde til konstruktion af bygninger
DK3384045T3 (da) Fremgangsmåde til bestemmelse af celleklonalitet
DK3152177T3 (da) Fremgangsmåde til ekspansion af sandkornformigt råmateriale
DK3687558T3 (da) Metaboliske biomarkører til forudsigelse af modtageligheden på fgf-18 forbindelse
DK3120153T3 (da) Cellulær-baseret fremgangsmåde til bestemmelse af muligheden for defibrotid
DK3507282T3 (da) Fremgangsmåde til fremstilling af indolcarboxamidforbindelser
DK3670618T3 (da) Fremgangsmåde til fremstilling af funktionaliserede polyestere
DK3700941T3 (da) Fremgangsmåde til fremstilling af modificeret hemicellulose
DK3283691T3 (da) Modulær struktur til installering af en kunstig spillebane
DK3259599T3 (da) Biomarkører til diagnosticering og prognose af ektatiske hornhindelidelser
DK3476838T3 (da) Fremgangsmåde til fremstilling af azoxystrobin